Home » Topics » Regulatory

Regulatory
RSS

Prialt receives FDA approval for severe chronic pain

Dec. 30, 2004

Clolar approved for pediatric ALL

Dec. 30, 2004

Finasteride tested to treat alcoholism

Dec. 30, 2004

Vfend approved for candidemia in nonneutropenic patients

Dec. 30, 2004

Pegvisomant may be effective in the treatment of breast cancer

Dec. 29, 2004

Advate approved in Europe for children under six with hemophilia A

Dec. 28, 2004

Animal results point to ATL-1102's potential in asthma

Dec. 27, 2004

Positive E.U. opinion for Pegasys combination therapy in HIV-HCV patients

Dec. 22, 2004

Macugen approved for neovascular AMD

Dec. 21, 2004

Fast track designation for Remicade for ulcerative colitis

Dec. 21, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.